StockData
Bruker Corp logo

Bruker Corp (BRKR) stock

BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30308% above fair value
$61.36+0.74 (+1.22%)

Close on Nov 17, 2026Market cap $9.52BP/E –Yield –

Bruker operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Bruker's operating income for the twelve months ending Jun 30, 2026 was -$30.60M, down 116.6% year over year. For fiscal 2025 it was $68.20M, down 73.1% from the year before. Over ten years it grew -7.3% a year on average. The highest annual figure on record is $436.90M in fiscal 2023.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$68.20M-73.1%
FY2024Dec 31, 2024$253.10M-42.1%
FY2023Dec 31, 2023$436.90M+1.0%
FY2022Dec 31, 2022$432.70M+4.7%
FY2021Dec 31, 2021$413.30M+66.5%
FY2020Dec 31, 2020$248.30M-17.5%
FY2019Dec 31, 2019$300.90M+14.7%
FY2018Dec 31, 2018$262.40M+19.5%
FY2017Dec 31, 2017$219.50M+20.7%
FY2016Dec 31, 2016$181.80M+24.8%
FY2015Dec 31, 2015$145.70M+38.2%
FY2014Dec 31, 2014$105.40M-28.9%
FY2013Dec 31, 2013$148.20M-5.0%
FY2012Dec 31, 2012$156.00M+0.3%
FY2011Dec 31, 2011$155.60M-0.1%
FY2010Dec 31, 2010$155.70M+13.9%
FY2009Dec 31, 2009$136.70M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$65.30M-648.7%
Q1 FY2026Mar 31, 2026$10.20M-67.9%
Q4 FY2025Dec 31, 2025$76.30M+5.8%
Q3 FY2025Sep 30, 2025-$51.80M-176.1%
Q2 FY2025Jun 30, 2025$11.90M-75.3%
Q1 FY2025Mar 31, 2025$31.80M-50.9%
Q4 FY2024Dec 31, 2024$72.10M-30.3%
Q3 FY2024Sep 30, 2024$68.10M-45.3%
Q2 FY2024Jun 30, 2024$48.10M-44.2%
Q1 FY2024Mar 31, 2024$64.80M-47.2%
Q4 FY2023Dec 31, 2023$103.50M-21.0%
Q3 FY2023Sep 30, 2023$124.50M-5.2%
Q2 FY2023Jun 30, 2023$86.20M+16.6%
Q1 FY2023Mar 31, 2023$122.70M+27.2%
Q4 FY2022Dec 31, 2022$131.00M+4.5%
Q3 FY2022Sep 30, 2022$131.30M+16.0%
Q2 FY2022Jun 30, 2022$73.90M-13.7%
Q1 FY2022Mar 31, 2022$96.50M+8.3%
Q4 FY2021Dec 31, 2021$125.40M+11.2%
Q3 FY2021Sep 30, 2021$113.20M+39.4%
Q2 FY2021Jun 30, 2021$85.60M+125.9%
Q1 FY2021Mar 31, 2021$89.10M+443.3%
Q4 FY2020Dec 31, 2020$112.80M-4.2%
Q3 FY2020Sep 30, 2020$81.20M-7.5%
Q2 FY2020Jun 30, 2020$37.90M-29.2%
Q1 FY2020Mar 31, 2020$16.40M-60.9%
Q4 FY2019Dec 31, 2019$117.70M+10.6%
Q3 FY2019Sep 30, 2019$87.80M+27.1%
Q2 FY2019Jun 30, 2019$53.50M+9.6%
Q1 FY2019Mar 31, 2019$41.90M+10.0%
Q4 FY2018Dec 31, 2018$106.40M+11.6%
Q3 FY2018Sep 30, 2018$69.10M+34.7%
Q2 FY2018Jun 30, 2018$48.80M+38.2%
Q1 FY2018Mar 31, 2018$38.10M+1.3%
Q4 FY2017Dec 31, 2017$95.30M+23.9%
Q3 FY2017Sep 30, 2017$51.30M+11.8%
Q2 FY2017Jun 30, 2017$35.30M–
Q1 FY2017Mar 31, 2017$37.60M–
Q4 FY2016Dec 31, 2016$76.90M–
Q3 FY2016Sep 30, 2016$45.90M–

More Bruker figures

See a number that looks wrong?